Plasma phospholipid fatty acid concentrations and risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST)

American Journal of Clinical Nutrition

Volumn 94, Issue 5, 2011, Pages 1304-1313

  Chajès, Véronique ^a,e   Jenab, Mazda ^a   Romieu, Isabelle ^a   Ferrari, Pietro ^a   Dahm, Christina C ^b,c   Overvad, Kim ^c   Egeberg, Rikke ^d   Tjønneland, Anne ^d   Clavel Chapelon, Françoise ^e   Boutron Ruault, Marie Christine ^e   Engel, Pierre ^e   Teucher, Birgit ^f   Kaaks, Rudolf ^f   Floegel, Anna ^g   Boeing, Heiner ^g   Trichopoulou, Antonia ^h   Dilis, Vardis ^h   Karapetyan, Tina ⁱ   Mattiello, Amalia ^j   Tumino, Rosario ^k   Grioni, Sara ^l,z   Palli, Domenico ^m   Vineis, Paolo ⁿ   Bueno de Mesquita, H Bas ^o,p   Numans, Mattijs E ^p   Peeters, Petra H M ^p   Lund, Eiliv ^q   Navarro, Carmen ^s,t   Quirós, Jose Ramón ^v   Sánchez Cantalejo, Emilio ^t,w   Gurrea, Aurelio Barricarte ^t,x   Dorronsoro, Miren ^t,y   Regnér, Sara ^a   Sonestedt, Emily ^aa   Wirfält, Elisabet ^aa   Khaw, Kay Tee ^ab   Wareham, Nick ^ac   Allen, Naomi E ^ad   Crowe, Francesca L ^ad   Rinaldi, Sabina ^a   Slimani, Nadia ^a   Carneiro, Fatima ^r   Riboli, Elio ^ae   González, Carlos A ^u   more..

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

^d INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^e HÔPITAL PAUL BROUSSE   (France)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^h UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

ⁱ HELLENIC HEALTH FOUNDATION   (Greece)

^j UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^k Civile MP Arezzo Hospital   (Italy)

^l NATIONAL CANCER INSTITUTE   (Italy)

^m CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

ⁿ UNIVERSITY OF TURIN   (Italy)

^o NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^p UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^q UNIVERSITY OF TROMSØ   (Norway)

^r University of Porto   (Portugal)

^s Regional Health Authority   (Spain)

^t CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^u CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^v Public Health and Health Planning Directorate   (Spain)

^w ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^x INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^y Public Health Division of Gipuzkoa   (Spain)

^z LUND UNIVERSITY HOSPITAL   (Sweden)

^aa LUND UNIVERSITY   (Sweden)

^ab UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ac MRC EPIDEMIOLOGY UNIT   (United Kingdom)

^ad UNIVERSITY OF OXFORD   (United Kingdom)

^ae IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; DIHOMO GAMMA LINOLENIC ACID; FATTY ACID; LINOLENIC ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; SATURATED FATTY ACID; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BODY MASS; CALORIC INTAKE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EDUCATIONAL STATUS; ENZYME ACTIVITY; FATTY ACID BLOOD LEVEL; FEMALE; GAS CHROMATOGRAPHY; HELICOBACTER INFECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; PROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; CASE-CONTROL STUDIES; COHORT STUDIES; EUROPE; FATTY ACIDS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; QUESTIONNAIRES; RISK FACTORS; STOMACH NEOPLASMS;

HELICOBACTER PYLORI;

EID: 80054887349     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.110.005892     Document Type: Article

References (54)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008, cancer incidence and mortality Worldwide: IARC CancerBase no. 10. Lyon, France: International Agency for Research on Cancer. 2010. Available from: http://globocan.iarc.fr (cited).
2. World Cancer Research Fund. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research, 2007.
3. Campbell PT, Sloan M, Kreiger N. Dietary patterns and risk of incident gastric adenocarcinoma. Am J Epidemiol 2008;167:295-304. (Pubitemid 351197586)
4. Navarro Silvera SA, Mayne ST, Risch H, Gammon MD, Vaughan TL, Chow WH, Dubrow R, Schoenberg JB, Stanford JL, West AB, et al. Food group intake and risk of subtypes of esophageal and gastric cancer. Int J Cancer 2008;123:852-60. (Pubitemid 352032412)
5. Tsugane S, Sasazuki S. Diet and the risk of gastric cancer: review of epidemiological evidence. Gastric Cancer 2007;10:75-83. (Pubitemid 46955941)
6. González CA, Pera G, Agudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, Schulz M, Del Giudice G, Plebani M, Carneiro F, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006;118:2559-66.
7. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003;78(suppl 3):559S-69S. (Pubitemid 40012550)
8. Tsugane S. Salt, salted food intake, and risk of gastric cancer: epidemiologic evidence. Cancer Sci 2005;96:1-6. (Pubitemid 40310017)
9. González CA, Jakszyn P, Pera G, Agudo A, Bingham S, Palli D, Ferrari P, Boeing H, del Giudice G, Plebani M, et al. Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:345-54. (Pubitemid 43338214)
10. Larsson SC, Bergkvist L, Wolk A. Processed meat consumption, dietary nitrosamines and stomach cancer risk in a cohort of Swedish women. Int J Cancer 2006;119:915-9. (Pubitemid 44051458)
11. Van den Brandt PA, Botterweck AA, Goldbohm RA. Salt intake, cured meat consumption, refrigerator use and stomach cancer incidence: a prospective cohort study (Netherlands). Cancer Causes Control 2003;14:427-38. (Pubitemid 36999977)
12. Jakszyn P, Bingham S, Pera G, Agudo A, Luben R, Welch A, Boeing H, Del Giudice G, Palli D, Saieva C, et al. Endogenous versus exogenous exposure to N-nitroso coumpounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPICEURGAST) study. Carcinogenesis 2006;27:1497-501. (Pubitemid 43985423)
13. López-Carrillo L, López-Cervantes M, Ward MH, Bravo-Alvarado J, Ramírez-Espitia A. Nutrient intake and gastric cancer in Mexico. Int J Cancer 1999;83:601-5. (Pubitemid 29508036)
14. Cornée J, Pobel D, Riboli E, Guyader M, Hémon B. A case-control study of gastric cancer and nutritional factors in Marseille, France. Eur J Epidemiol 1995;11:55-65.
15. Kaaks R, Tuyns AJ, Haelterman M, Riboli E. Nutrient intake patterns and gastric cancer risk: a case-control study in Belgium. Int J Cancer 1998;78:415-20. (Pubitemid 28481157)
16. Saadatian-Elahi M, Slimani N, Chajès V, Jenab M, Goudable J, Biessy C, Ferrari P, Byrnes G, Autier P, Peeters PH, et al. Plasma phospholipid fatty acid profiles and their association with food intakes: Results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC). Am J Clin Nutr 2009;89:331-46.
17. Baylin A, Campos H. The use of fatty acid biomarkers to reflect dietary intake. Curr Opin Lipidol 2006;17:22-7. (Pubitemid 43100299)
18. Bingham S, Riboli E. Diet and cancer - the European Prospective Investigation into Cancer and Nutrition. Nat Rev Cancer 2004;4:206-15. (Pubitemid 38337500)
19. Riboli E, Kaaks R. The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(suppl 1):S6-14.
20. Epplein M, Nomura AM, Hankin JH, Blaser MJ, Perez-Perez G, Stemmermann GN, Wilkens LR, Kolonel LN. Association of Helicobacter pylori infection and diet on the risk of gastric cancer: a case-control study in Hawaii. Cancer Causes Control 2008;19:869-77.
21. Palli D, Masala G, Del Guidice G, Plebani M, Basso D, Berti D, Numans ME, Ceroti M, Peeters PH, Bueno de Mesquita HB, et al. CagA+ Helicobacter pylori infection and gastric cancer risk in the EPIC-EURGAST study. Int J Cancer 2007;120:859-67. (Pubitemid 46175407)
22. Jenab M, Riboli E, Ferrari P, Friesen M, Sabate J, Norat T, Slimani N, Tjønneland A, Olsen A, Overvad K, et al. Plasma and dietary carotenoid, retinal and tocopherol levels and the risk of gastric adenocarcinomas in the European Prospective Investigation into Cancer and Nutrition. Br J Cancer 2006;95:406-15. (Pubitemid 44187608)
23. Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondière UR, Hémon B, Casagrande C, Vignat J, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 2002;5:1113-24. (Pubitemid 36313608)
24. Chajès V, Hulten K, van Kappel AL, Winkvist A, Kaaks R, Hallmans G, Lenner P, Riboli E. Fatty acid composition in serum phospholipids and risk of breast cancer: an incident case-control study in Sweden. Int J Cancer 1999;83:585-90. (Pubitemid 29508033)
25. Freisling H, Fahey MT, Moskal A, Ocké MC, Ferrari P, Jenab M, Norat T, Naska A, Welch AA, Navarro C, et al. Region-specific nutrient intake patterns exhibit a geographical gradient within and between European countries. J Nutr 2010;140:1280-6.
26. Kuriki K, Wakai K, Matsuo K, Hiraki A, Suzuki T, Yamamura Y, Yamao K, Nakamura T, Tatematsu M, Tajima K. Gastric cancer risk and erythrocyte composition of docosahexaenoic acid with anti-inflammatory effects. Cancer Epidemiol Biomarkers Prev 2007;16:2406-15. (Pubitemid 351196374)
27. Chajès V, Thiébaut A, Rotival M, Gauthier E, Maillard V, Boutron-Ruault MC, Joulin V, Lenoir GM, Clavel-Chapelon F. Association between serum trans-monounsaturated fatty acids and breast cancer risk in the E3N-EPIC Study. Am J Epidemiol 2008;167:1312-20. (Pubitemid 351770558)
28. Pala V, Krogh V, Muti P, Chajès V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F. Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 2001;93:1088-95. (Pubitemid 32717541)
29. Thiébaut AC, Rotival M, Gauthier E, Lenoir G, Boutron-Ruault MC, Joulin V, Clavel-Chapelon F, Chajès V. Correlation between serum phospholipid fatty acids and dietary intakes assessed a few years earlier. Nutr Cancer 2009;61:500-9.
30. Swinnen JV, Vanderhoydonc F, Elagamal AA, Eelen M, Vercaeren I, Joniau S, Van Poppel H, Baert L, Goossens K, Heyns W, et al. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int J Cancer 2000;88:176-9.
31. Scaglia N, Caviglia JM, Igal RA. High stearoyl-CoA desaturase protein and activity levels in simian virus 40 transformed-human lung fibroblasts. Biochim Biophys Acta 2005;1687:141-51.
32. Bougnoux P, Chajès V, Lanson M, Hacene K, Body G, Couet C, Le Floch O. Prognostic significance of tumor phosphatidylcholine stearic acid level in breast carcinoma. Breast Cancer Res Treat 1992;20:185-94.
33. Miyazaki M, Kim YC, Gray-Keller MP, Attie AD, Ntambi JM. The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J Biol Chem 2000;275:30132-8.
34. Yahagi N, Shimano H, Hasegawa K, Ohashi K, Matsuzaka T, Najima Y, Sekiya M, Tomita S, Okazaki H, Tamura Y, et al. Coordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 2005;41:1316-22. (Pubitemid 40813009)
35. Kumar-Sinha C, Ignatoski KW, Lippman ME, Ethier SP, Chinnaiyan AM. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res 2003;63:132-9. (Pubitemid 36070431)
36. Scaglia N, Chisholm JW, Igal RA. Inhibition of stearoylCoA desaturase-1 inactivates acetyl-CoA carboxylase and impairs proliferation in cancer cells: role of AMPK. PLoS ONE 2009;4:e6812.
37. Scaglia N, Igal RA. Inhibition of stearoyl-CoA desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis. Int J Oncol 2008;33:839-50.
38. Chajès V, Joulin V, Clavel-Chapelon F. The fatty acid desaturation index of blood lipids, as a biomarker of hepatic stearoyl-CoA desaturase expression, is a predictive factor of breast cancer risk. Curr Opin Lipidol 2011;22:6-10.
39. Martin CA, Milinsk MC, Visentainer JV, Matsushita M, De Souza NE. Trans fatty acid-forming processes in foods: a review. An Acad Bras Cienc 2007;79:343-50. (Pubitemid 47150648)
40. Bougnoux P, Giraudeau B, Couet C. Diet, cancer, and the lipidome. Cancer Epidemiol Biomarkers Prev 2006;15:416-21.
41. Vinikoor LC, Millikan RC, Satia JA, Schroeder JC, Martin CF, Ibrahim JG, Sandler RS. Trans fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II. Cancer Causes Control 2010;21:171-80.
42. Chavarro JE, Stampfer MJ, Campos H, Kurth T, Willett WC, Ma J. A prospective study of trans fatty acid levels in blood and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2008;17:95-101. (Pubitemid 351196278)
43. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol 2006;12:1336-45.
44. Smith WL, De Witt DL, Garavito RM. Cyclooxygenase: structural, cellular, and molecular biology. Annu Rev Biochem 2000;69:145-82.
45. Wang WH, Huang JQ, Zheng GF, Lam SK, Karlberg J, Wong BC. Non-steroidal anti-inflammatory drug use and the risk of gastric cancer: a systematic review and meta-analysis. J Natl Cancer Inst 2003;95:1784-91. (Pubitemid 38008901)
46. Chavarro JE, Stampfer MJ, Li H, Campos H, Kurth T, Ma J. A prospective study of polyunsaturated fatty acid levels in blood and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1364-70. (Pubitemid 47076865)
47. González CA, Sanz JM, Marcos G, Pita S, Brullet E, Saigi E, Badia A, Agudo A, Riboli E. Borage consumption as a possible gastric cancer protective factor. Cancer Epidemiol Biomarkers Prev 1993;2:157-8.
48. De Stéfani E, Deneo-Pellegrini H, Mendilaharsu M, Ronco A. Essential fatty acids and breast cancer: a case-control study in Uruguay. Int J Cancer 1998;76:491-4. (Pubitemid 28227990)
49. Daniel CR, McCullough ML, Patel RC, Jacobs EJ, Flanders WD, Thun MJ, Calle EE. Dietary intake of ω-6 and ω-3 fatty acids and risk of colorectal cancer in a prospective cohort of U.S. men and women. Cancer Epidemiol Biomarkers Prev 2009;18:516-25.
50. Crowe FL, Allen NE, Appleby PN, Overvad K, Aardestrup IV, Johnsen NF, Tjønneland A, Linseisen J, Kaaks R, Boeing H, et al. Fatty acid composition of plasma phospholipids and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2008;88:1353-63.
51. Leitzmann MF, Stampfer MJ, Michaud DS, Augustsson K, Colditz GC, Willett WC, Giovannucci EL. Dietary intake of n-3 and n-6 fatty acids and the risk of prostate cancer. Am J Clin Nutr 2004;80:204-16.
52. De Stéfani E, Deneo-Pellegrini H, Boffetta P, Ronco A, Mendilaharsu M. α-linolenic acid and risk of prostate cancer: a case-control study in Uruguay. Cancer Epidemiol Biomarkers Prev 2000;9:335-8. (Pubitemid 30165448)
53. Thiébaut AC, Chajès V, Gerber M, Boutron-Ruault MC, Joulin V, Lenoir G, Berrino F, Riboli E, Bénichou J, Clavel-Chapelon F. Dietary intakes of ω-6 and ω-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 2009;124:924-31.
54. Eussen SJ, Vollset SE, Hustad S, Midttun Ø, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Ferrari P, et al. Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2010;19:28-38.